➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Express Scripts
Moodys
AstraZeneca
Medtronic

Last Updated: January 24, 2021

DrugPatentWatch Database Preview

Litigation Details for Endo Pharmaceuticals Inc. v. Actavis LLC (D. Del. 2014)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Endo Pharmaceuticals Inc. v. Actavis LLC
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Endo Pharmaceuticals Inc. v. Actavis LLC (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-11-07 1 6. This is an action for patent infringement arising under the Patent Laws of the United States, …THE ’737 PATENT 21. On August 19, 2014, the PTO duly and legally issued U.S. Patent No. 8,808,737…the ’737 Patent. 23. Opana ER CRF is covered by one or more claims of the ’737 Patent. … 24. Endo has submitted patent information regarding the ’737 Patent for listing by the FDA in the…THE ’779 PATENT 25. On October 28, 2014, the PTO duly and legally issued U.S. Patent No. 8,871,779 External link to document
2016-05-13 119 STIPULATION and Order Regarding U.S. Patent No. 8,871,779, by Endo Pharmaceuticals Inc., Mallinckrodt… 15 September 2017 1:14-cv-01381 830 Patent None District Court, D. Delaware External link to document
2015-01-20 12 infringed U.S. Patents 8,808,737 (“the ‘737 patent”) and 8,871,779 (“the ‘779 patent”) by (i) selling…infringement of the ‘737 patent Because the ‘737 patent is directed to methods of treatment… of the ‘737 patent For method-of-treatment claims like those in the ‘737 patent, an applicant…language to exemplary Claim 1 of the ‘737 patent: Claim 1 of the patent held invalid in Mayo …in a way to create a patent-eligible process. Id. at 1298. The ‘737 patent has many of the same External link to document
2016-05-16 120 119 Stipulation and Order Regarding U.S. Patent No. 8,871,779, filed by Mallinckrodt LLC, Endo Pharmaceuticals… 15 September 2017 1:14-cv-01381 830 Patent None District Court, D. Delaware External link to document
2016-09-19 123 Davies, D. Phil. Regarding Validity of U.S. Patent No. 8,871,779 filed by Endo Pharmaceuticals Inc., Mallinckrodt… 15 September 2017 1:14-cv-01381 830 Patent None District Court, D. Delaware External link to document
2016-12-05 138 Davies, D.Phil. Regarding Validity of U.S. Patent No. 8,871,779 filed by Endo Pharmaceuticals Inc., Mallinckrodt… 15 September 2017 1:14-cv-01381 830 Patent None District Court, D. Delaware External link to document
2015-02-27 18 relating to one of the two patents-in- suit—U.S. Patent No. 8,808,737 (“the ’737 Patent”). No other defendant… that the first two patents’ claims were patent eligible, while the third patent’s claims were not. Id… A. The ’737 Patent Is Directed to Patentable Subject Matter— …indirect infringement of the ’737 Patent, and that the claims of the ’737 Patent are directed to unpatentable…are thus directed to a patent eligible “new and useful process,” not a patent ineligible abstract idea External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Express Scripts
Colorcon
Mallinckrodt
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.